"
State of the HIV, Hepatitis B and C Virus Pandemic from 2003 to 2022 in Burkina Faso: Evolution of Prevalence Trends and Strategic Recommendations to Achieve the WHO’s Goal for Their Eradication by 2030"
written by Abdou Azaque Zouré, Christelle Nadembega, Djénéba Ouermi, Abdoul Karim Ouattara, Lassina Traoré, Adama Tiemtoré, Olivier Sawadogo, Théodora M. Zohoncon, Florencia W. Djigma, Jacques Simpore, Cerba-Labiogene Group,
published by
Advances in Infectious Diseases,
Vol.14 No.3, 2024
has been cited by the following article(s):
|
[1]
|
Epidemiology of Hepatitis B and Syphilis in Ouagadougou (2013-2024): Screening, Prevalence and Drug Treatment
American Journal of Molecular Biology,
2026
DOI:10.4236/ajmb.2026.161007
|
|
|
|
|
[2]
|
Prevention, Screening and Treatment of HIV and Hepatitis C in Burkina Faso (2013-2024): Progress towards Eradication
Advances in Infectious Diseases,
2025
DOI:10.4236/aid.2025.154058
|
|
|
|
|
[3]
|
Mathematical modelling of the impact of vaccination, treatment and media awareness on the hepatitis B epidemic in Burkina Faso
Mathematical Modelling and Numerical Simulation with Applications,
2024
DOI:10.53391/mmnsa.1528691
|
|
|
|